1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TLDC2 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA TMEM19 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA DKK4 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA ANTXRL CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA LY6L CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA ITGA2 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA SMYD4 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA GSTK1 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA FNTB CTRPv2 pan-cancer AAC 0.18 3e-05
mRNA TSNAX CTRPv2 pan-cancer AAC 0.16 3e-05
Download CSV